Brief: Pediapharm posts Q3 revenue $1.77 mln, up 73 pct
Feb 28 (Reuters) - Pediapharm Inc PDP.V
* Pediapharm announces third quarter financial results - 73
pct increase in revenue
* Pediapharm Inc - NYDA is expected to reach $4.2 million -
$4.4 million in fiscal 2017
* Qtrly total revenue reached $1.77 million representing an
increase of 73 pct
Source text for Eikon: ID:nCCNc4tVjf
Further company coverage: PDP.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Medexus Pharmaceuticals
See all newsCanada's Medexus Q4 revenue misses analyst expectations, net loss widens
Brief: Medexus Pharmaceuticals Q4 Revenue USD 24.652 Million Vs. IBES Estimate USD 25.6 Million
Canada Research Roundup: CAE, Medexus Pharmaceuticals, TCP Energy
Medexus Pharma Q2 revenue misses estimates
Brief: Medexus Pharmaceuticals Q2 Revenue USD 24.741 Million Vs. IBES Estimate USD 25.6 Million